January 2, 2018 - The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Robbins LLP's shareholder rights attorneys & securities litigation law firm specializes in stockholder rights law. Try our free investment monitoring service.

October 27, 2021 - We cannot provide a description for this page right now

August 9, 2018 - Take a look at All News Releases related news releases, photos and videos distributed by PRWeb, with investor relations and company news.

October 9, 2019 - This phase 2a study will assess the exploratory efficacy, as well as the local and systemic safety of single and repeat intratympanic doses of FX-322 compared to placebo in approximately 96 subjects with stable mild to moderately severe sensorineural hearing loss, with a medical history consistent ...

Frequency Therapeutics

Hearing loss affects millions of people -- so why doesn't it get more attention? And why isn't it taken more seriously? Why are treatment advances so slow? We're looking to change that, by showing what it's really like to be living every day with a challenge that affects virtually every facet ...

March 23, 2021 - Daily news and analysis of the global biotechnology, pharmaceutical and medical technology industries.

February 23, 2021 - Frequency Therapeutics Inc (NASDAQ: FREQ) has announced the publication of its lead candidate FX-322 Phase 1/2 study results in Otology & Neurotology.

December 18, 2020 - The company's flagship product candidate, FX-322, is under clinical development for the treatment of sensorineural hearing loss, the most common type of hearing impairment. FX-322 has shown promising results in early-phase clinical trials, indicating a potential breakthrough in a field where ...

October 12, 2022 - Hearing News Watch. Timely information and lively insights for everyone who cares about hearing loss.

May 6, 2021 - Join Seeking Alpha, the largest investing community in the world. Get stock market news and analysis, investing ideas, earnings calls, charts and portfolio analysis tools.

December 9, 2021 - RTTNews delivers the latest news from around the world covering business, economics, politics, forex, market analysis, stocks to watch, entertainment, audio, video and photos.

March 25, 2021 - What’s promising? What’s available soon? Current topics include CS0022 (BMS-191011), FX-322, OTO-313, Susan Shore device, NHPN-1010, Lenire, GW-201 (GW-TT1), Jianxin Bao, tetrandrine, OtoBand, Sulodexide, 6B-001, and more. News Research Clinical Trials Projects Discussion

A discovery platform for Eastern Virginia Medical School's expertise and scholarly output Browse or search information on people, departments, clinical trials, and publications · Scroll down for more

Hearing loss drug developer Frequency Therapeutics (NASDAQ: FREQ) is the subject of a growing number of security fraud accusations on behalf of investors. Earlier this year, things were looking up for the company’s lead product candidate, FX-322.

March 7, 2022 - To evaluate the safety of the Investigational Product and explore its effectiveness in restoring hearing function by regenerating cells in the ear that are necessary for healthy hearing.

February 13, 2023 - RTTNews delivers the latest news from around the world covering business, economics, politics, forex, market analysis, stocks to watch, entertainment, audio, video and photos.

Daily news and analysis of the global biotechnology, pharmaceutical and medical technology industries.

September 29, 2020 - Frequency Therapeutics, a Boston-based biopharmaceutical company, is developing a potential hearing loss treatment like nothing before.